UBS Group’s Celcuity CELC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $54.5M | Buy |
520,946
+300,783
| +137% | +$34.7M | 0.01% | 1661 |
|
|
2026
Q1 | $25.1M | Buy |
220,163
+138,592
| +170% | +$15.1M | ﹤0.01% | 2348 |
|
|
2025
Q4 | $8.14M | Sell |
81,571
-772,912
| -90% | -$63.5M | ﹤0.01% | 3514 |
|
|
2025
Q3 | $42.2M | Buy |
854,483
+769,891
| +910% | +$30.8M | 0.01% | 1804 |
|
|
2025
Q2 | $1.13M | Buy |
84,592
+16,353
| +24% | +$178K | ﹤0.01% | 5344 |
|
|
2025
Q1 | $690K | Sell |
68,239
-15,675
| -19% | -$177K | ﹤0.01% | 5594 |
|
|
2024
Q4 | $1.1M | Buy |
83,914
+10,631
| +15% | +$150K | ﹤0.01% | 5229 |
|
|
2024
Q3 | $1.09M | Buy |
73,283
+35,638
| +95% | +$587K | ﹤0.01% | 4580 |
|
|
2024
Q2 | $617K | Sell |
37,645
-11,662
| -24% | -$195K | ﹤0.01% | 4838 |
|
|
2024
Q1 | $1.07M | Sell |
49,307
-3,534
| -7% | -$56.4K | ﹤0.01% | 4552 |
|
|
2023
Q4 | $770K | Buy |
52,841
+39,823
| +306% | +$481K | ﹤0.01% | 4725 |
|
|
2023
Q3 | $119K | Sell |
13,018
-348
| -3% | -$3.42K | ﹤0.01% | 5715 |
|
|
2023
Q2 | $147K | Buy |
13,366
+8,322
| +165% | +$86.5K | ﹤0.01% | 5705 |
|
|
2023
Q1 | $51.7K | Sell |
5,044
-64
| -1% | -$701 | ﹤0.01% | 6428 |
|
|
2022
Q4 | $71.6K | Buy |
5,108
+773
| +18% | +$7.91K | ﹤0.01% | 6426 |
|
|
2022
Q3 | $44K | Sell |
4,335
-977
| -18% | -$9.22K | ﹤0.01% | 6462 |
|
|
2022
Q2 | $48K | Sell |
5,312
-1,663
| -24% | -$12.2K | ﹤0.01% | 5947 |
|
|
2022
Q1 | $65K | Sell |
6,975
-30,033
| -81% | -$312K | ﹤0.01% | 6236 |
|
|
2021
Q4 | $488K | Buy |
37,008
+3,413
| +10% | +$54.6K | ﹤0.01% | 4999 |
|
|
2021
Q3 | $605K | Buy |
33,595
+3,574
| +12% | +$75.8K | ﹤0.01% | 4589 |
|
|
2021
Q2 | $721K | Sell |
30,021
-236
| -0.8% | -$6.07K | ﹤0.01% | 4460 |
|
|
2021
Q1 | $434K | Buy |
30,257
+3,974
| +15% | +$56.5K | ﹤0.01% | 4979 |
|
|
2020
Q4 | $241K | Buy |
26,283
+6,283
| +31% | +$50.4K | ﹤0.01% | 5122 |
|
|
2020
Q3 | $116K | Hold |
20,000
| – | – | ﹤0.01% | 5096 |
|
|
2020
Q2 | $139K | Sell |
20,000
-2,955
| -13% | -$20.8K | ﹤0.01% | 5062 |
|
|
2020
Q1 | $149K | Buy |
22,955
+15,204
| +196% | +$142K | ﹤0.01% | 4951 |
|
|
2019
Q4 | $82K | Sell |
7,751
-17,128
| -69% | -$224K | ﹤0.01% | 6096 |
|
|
2019
Q3 | $423K | Buy |
24,879
+4,645
| +23% | +$91.7K | ﹤0.01% | 4702 |
|
|
2019
Q2 | $506K | Sell |
20,234
-821
| -4% | -$18.1K | ﹤0.01% | 4291 |
|
|
2019
Q1 | $461K | Buy |
21,055
+3,729
| +22% | +$81.8K | ﹤0.01% | 4112 |
|
|
2018
Q4 | $416K | Buy |
17,326
+946
| +6% | +$24.6K | ﹤0.01% | 4407 |
|
|
2018
Q3 | $471K | Buy |
16,380
+672
| +4% | +$16.9K | ﹤0.01% | 4450 |
|
|
2018
Q2 | $390K | Buy |
15,708
+14,312
| +1,025% | +$278K | ﹤0.01% | 4501 |
|
|
2018
Q1 | $23K | Buy |
1,396
+848
| +155% | +$14.8K | ﹤0.01% | 6301 |
|
|
2017
Q4 | $10K | Buy |
548
+91
| +20% | +$1.6K | ﹤0.01% | 7005 |
|
|
2017
Q3 | $6K | Buy |
+457
| New | +$6.08K | ﹤0.01% | 7134 |
|
Other funds holding CELC
BBA
ACA
RI
PA
NMC
SCM
UBS Group's CELC Position: Q2 2026 in Review
UBS Group increased its Celcuity (CELC) stake by 137% in Q2 2026, buying an estimated $34.7M and bringing the position to 520,946 shares worth $54.5M. The position accounts for 0.01% of the portfolio, ranked #1661.
UBS Group first reported a position in CELC in Q3 2017 and has held it in 36 quarters since. 274 funds tracked by Wall St. Rank hold CELC as of Q2 2026.
- UBS Group held 520,946 shares of Celcuity worth $54.5M as of Q2 2026.
- UBS Group bought 300,783 Celcuity shares in Q2 2026, an estimated $34.7M.
- Celcuity made up 0.01% of UBS Group's portfolio in Q2 2026, its #1661 holding.
- UBS Group first reported a position in Celcuity in Q3 2017 and has held it in 36 quarters since.
- 274 funds tracked by Wall St. Rank held Celcuity as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.